相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
Rudolf L. Then et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone
Sang-Guk Lee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Genetics of Chromosomally Mediated Intermediate Resistance to Ceftriaxone and Cefixime in Neisseria gonorrhoeae
Shuqing Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Meeting the public health challenge of multidrug- and extensively drug-resistantNeisseria gonorrhoeae
John W Tapsall et al.
Expert Review of Anti-Infective Therapy (2009)
Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales
S. A. Chisholm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes
Magnus Unemo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci
J. W. Tapsall
SEXUALLY TRANSMITTED INFECTIONS (2009)
Emerging antimicrobial resistance in Neisseria gonorrhoeae:: Urgent need to strengthen prevention strategies
Kimberly A. Workowski et al.
ANNALS OF INTERNAL MEDICINE (2008)
The Neisseria gonorrhoeae population in Sweden during 2005-phenotypes, genotypes and antibiotic resistance
Birgitta Olsen et al.
APMIS (2008)
Recent advances in bacterial topoisomerase inhibitors
Barton J. Bradbury et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland
Helen M. Palmer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece
Eva Tzelepi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone
David M. Whiley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone:: Association with genetic polymorphisms in penA, mtrR, porB1b, and ponA
Robert Lindberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain
Magnus Unemo et al.
APMIS (2007)
In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents
J. A. Vazquez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit
JW Mouton et al.
CLINICAL THERAPEUTICS (2005)
Which cephalosporin for gonorrhoea?
CA Ison et al.
SEXUALLY TRANSMITTED INFECTIONS (2004)
Use of Monte Carlo Simulations to select therapeutic doses and provisional breakpoints of BAL9141
JW Mouton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid
WA Craig
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Mosaic-like structure of penicillin-binding protein 2 gene (PenA) in clinical isolates of Neissetia gonorrhoeae with reduced susceptibility to cefixime
S Ameyama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
分享论文
